LISLE, Ill., Jan. 03, 2018 -- CTS Corporation (NYSE:CTS) will be presenting at the 20th Annual Needham Growth Conference in New York City on January 17th, 2018 at 12:00 p.m. (Eastern Time). The Needham Growth Conference focuses on growth companies from a broad range of industries. Additional information about the conference is available at http://www.needhamco.com. CTS’s investor presentation is available on the Investors page of www.ctscorp.com for those unable to attend.
About CTS
CTS (NYSE:CTS) is a leading designer and manufacturer of products that Sense, Connect and Move. CTS manufactures sensors, actuators and electronic components in North America, Europe and Asia, and supplies these products to OEMs in the aerospace, communications, defense, industrial, information technology, medical and transportation markets.
For more information, visit www.ctscorp.com.
Contact
Ashish Agrawal
Vice President and Chief Financial Officer
CTS Corporation
2375 Cabot Drive
Lisle, IL 60532
USA
Telephone: +1 (630) 577-8800
E-mail: [email protected]


How Marco Pharma International Preserves German Homeopathic Traditions in America
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
FTC Questions Apple News Over Alleged Bias Against Conservative Media
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week 



